Cargando…

Comparison of Intraocular Pressure, Blood Pressure, Ocular Perfusion Pressure and Blood Flow Fluctuations During Dorzolamide Versus Timolol Add-On Therapy in Prostaglandin Analogue Treated Glaucoma Subjects

Objective: To compare the effects of dorzolamide and timolol add-on therapy in open-angle glaucoma (OAG) patients previously treated with prostaglandin analogue (Pg), by evaluating fluctuations in the intraocular (IOP), blood (BP), ocular perfusion pressures (OPP) and retrobulbar blood flow (RBF) pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Januleviciene, Ingrida, Siaudvytyte, Lina, Diliene, Vaida, Barsauskaite, Ruta, Paulaviciute-Baikstiene, Daiva, Siesky, Brent, Harris, Alon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763637/ https://www.ncbi.nlm.nih.gov/pubmed/24281382 http://dx.doi.org/10.3390/ph5030325

Ejemplares similares

The Effect of Diluted Penetration Enhancer in Nebulized Mist versus Liquid Drop Preparation Forms on Retrobulbar Blood Flow in Healthy Human Subjects
por: Primus, Sally, et al.
Publicado: (2012)

Ophthalmic Drug Delivery in Glaucoma—A Review
por: Januleviciene, Ingrida, et al.
Publicado: (2012)

Evaluation of Outflow Structures In Vivo after the Phacocanaloplasty
por: Paulaviciute-Baikstiene, Daiva, et al.
Publicado: (2016)

The Difference in Translaminar Pressure Gradient and Neuroretinal Rim Area in Glaucoma and Healthy Subjects
por: Siaudvytyte, Lina, et al.
Publicado: (2014)

The Relationship between Intracranial Pressure and Visual Field Zones in Normal-Tension Glaucoma Patients
por: Stoskuviene, Akvile, et al.
Publicado: (2023)

Comparison of Latanoprost/Timolol with Carbonic Anhydrase Inhibitor and Dorzolamide/Timolol with Prostaglandin Analog in the Treatment of Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2014)

Rational use of the fixed combination of dorzolamide – timolol in the management of raised intraocular pressure and glaucoma
por: Yeh, Jason, et al.
Publicado: (2008)

Can the Treatment of Normal-Pressure Hydrocephalus Induce Normal-Tension Glaucoma? A Narrative Review of a Current Knowledge
por: Hamarat, Yasin, et al.
Publicado: (2021)

Additive intraocular pressure-lowering effect of dorzolamide 1%/timolol 0.5% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2011)

Comparison of Intraocular Pressure Fluctuations Measured by Goldmann Applanation Tonometer and Pulsatile Ocular Blood Flow Analyser
por: Januleviciene, Ingrida, et al.
Publicado: (2006)

Effect of 3 years of treatment with a dorzolamide/timolol (1%/0.5%) combination on intraocular pressure
por: Takeda, Sakurako, et al.
Publicado: (2014)

Literature review and meta-analysis of translaminar pressure difference in open-angle glaucoma
por: Siaudvytyte, L, et al.
Publicado: (2015)

The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma
por: Stankiewicz, Andrzej, et al.
Publicado: (2010)

Efficacy and Tolerability of the Fixed Combinations Latanoprost/Timolol versus Dorzolamide/Timolol in Patients with Elevated Intraocular Pressure: A Meta-Analysis of Randomized Controlled Trials
por: He, Miao, et al.
Publicado: (2013)

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
por: Lo, Jonathan S, et al.
Publicado: (2016)

Location of the internal carotid artery and ophthalmic artery segments for non-invasive intracranial pressure measurement by multi-depth TCD
por: Hamarat, Yasin, et al.
Publicado: (2017)

Effect of dorzolamide/timolol combination on the visual field in glaucoma
por: Takeda, Sakurako, et al.
Publicado: (2014)

Prospective Clinical Study of Non-Invasive Intracranial Pressure Measurements in Open-Angle Glaucoma Patients and Healthy Subjects
por: Deimantavicius, Mantas, et al.
Publicado: (2020)

Intraocular pressure reduction of fixed combination timolol maleate 0.5% and dorzolamide 2% (Cosopt) administered three times a day
por: Shemesh, Gabi, et al.
Publicado: (2012)

Comparison of the Effects of Dorzolamide/Timolol Fixed Combination versus Latanoprost on Intraocular Pressure and Ocular Perfusion Pressure in Patients with Normal-Tension Glaucoma: A Randomized, Crossover Clinical Trial
por: Lee, Na Young, et al.
Publicado: (2016)

Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
por: Aihara, Makoto, et al.
Publicado: (2017)

Graphical and statistical analyses of the oculocardiac reflex during a non-invasive intracranial pressure measurement
por: Hamarat, Yasin, et al.
Publicado: (2018)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
por: Teus, Miguel A, et al.
Publicado: (2009)

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study
por: Galose, Mary S, et al.
Publicado: (2016)

Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma
por: Janulevičienė, Ingrida, et al.
Publicado: (2012)

Photodynamic Therapy and Central Serous Chorioretinopathy
por: Siaudvytyte, Lina, et al.
Publicado: (2012)

A comparative study on the efficacy, safety, and cost-effectiveness of bimatoprost/timolol and dorzolamide/timolol combinations in glaucoma patients
por: Jothi, R., et al.
Publicado: (2010)

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
por: Shimizu, Yoshie, et al.
Publicado: (2015)

Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
por: Inatani, Masaru, et al.
Publicado: (2023)

The effects of topical dorzolamide 2% and brinzolamide 1%, either alone or combined with timolol 0.5%, on intraocular pressure, pupil diameter, and heart rate in healthy cats
por: Slenter, Inge J. M., et al.
Publicado: (2019)

Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
por: Ichhpujani, Parul, et al.
Publicado: (2010)

Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops
por: Kim, Myungjin, et al.
Publicado: (2021)

Dorzolamide/Timolol Fixed Combination: Learning from the Past and Looking Toward the Future
por: Konstas, Anastasios G., et al.
Publicado: (2020)

Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online
por: Merczel, Sára, et al.
Publicado: (2023)

Evaluation of Hemodynamic Parameters as Predictors of Glaucoma Progression
por: Janulevičiene, Ingrida, et al.
Publicado: (2011)

Changes in ocular morphology after cataract surgery in open angle glaucoma patients
por: Pakuliene, Giedre, et al.
Publicado: (2021)

Differences in structural parameters in patients with open-angle glaucoma, high myopia and both diseases concurrently. A pilot study
por: Markeviciute, Agne, et al.
Publicado: (2023)

Update and critical appraisal of combined timolol and carbonic anhydrase inhibitors and the effect on ocular blood flow in glaucoma patients
por: Moss, Adam M, et al.
Publicado: (2010)

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/timolol among patients with open-angle glaucoma or ocular hypertension
por: Sanseau, Ana, et al.
Publicado: (2013)

Patient perspectives when switching from Cosopt(®) (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy
por: Auger, Graham Anthony, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2rhr0qkeiuk52bfit0dc85hti0